Today: 21 May 2026
Delta Air Lines stock slides again after 2026 outlook — here’s what investors watch next
14 January 2026
2 mins read

Delta Air Lines stock slides again after 2026 outlook — here’s what investors watch next

NEW YORK, Jan 14, 2026, 14:40 EST — Regular session

  • Delta shares dropped roughly 2% after the company issued a cautious profit forecast for 2026
  • Carrier forecasted adjusted EPS between $6.50 and $7.50 for 2026, alongside $3 billion to $4 billion in free cash flow
  • A filing reveals Delta has committed to purchasing 30 Boeing 787-10s, plus options for an additional 30, with deliveries set to begin in 2031

Shares of Delta Air Lines, Inc. (DAL) dropped roughly 2% to $67.97 in Wednesday afternoon trading, extending losses following the airline’s annual outlook and fleet update released the day before. United Airlines, American Airlines, and Southwest Airlines also saw declines.

This is significant as Delta stands among the first big U.S. carriers to lay out a specific profit forecast for the coming year. Investors are treating this as a gauge for demand’s strength heading into 2026 and spotting where pricing leverage might be slipping.

Airlines continue to make a profit on premium seats, yet economy tickets keep planes full. The market’s weighing if this balance will tilt back or hold steady.

Delta reported an adjusted $1.55 per share for the December quarter, with adjusted operating revenue hitting $14.6 billion. The airline expects full-year 2026 adjusted earnings per share between $6.50 and $7.50, alongside free cash flow of $3 billion to $4 billion after capital expenditures. It also anticipates March-quarter revenue growth of 5% to 7%. “2026 is off to a strong start,” said CEO Ed Bastian. Delta Air Lines

Delta has been upfront about where demand is lagging. Main-cabin ticket revenue dropped 7% in the December quarter, even as premium product revenue climbed 9%. CEO Ed Bastian noted that “the lower-end consumer is struggling.” Executives said a rebound in main-cabin demand will be crucial to hit the upper end of their 2026 forecast. Reuters

A filing revealed that Delta struck a deal on Jan. 12 to buy 30 Boeing 787-10 planes, plus an option for 30 additional jets. Deliveries are scheduled to start in 2031, and the aircraft will be powered by GEnx engines from General Electric, the filing noted.

The sell-off unfolded alongside broader U.S. market losses, led by banks and tech stocks, while oil prices climbed. Rising crude costs often push up jet fuel prices, a key variable in airline profit margins.

Delta’s situation isn’t one-sided. It’s counting on wealthier leisure travelers and business flyers to sustain strong yields, but that reliance could backfire quickly if the economy slows or firms tighten travel spending.

Fuel remains a wild card. A sudden spike can squeeze earnings before fares adjust, and airlines usually delay passing on those costs to avoid losing passengers.

Delta President Glen Hauenstein pointed to the standard cabin as the key pressure point. “That’s just how the math has to work,” he said during the company’s earnings call, according to a transcript cited by Investopedia, highlighting the need for main-cabin fares to increase over time. Investopedia

Investors now turn their attention to the broader sector, beginning with American Airlines’ Q4 and full-year 2025 earnings call scheduled for Jan. 27 at 7:30 a.m. CT.

Stock Market Today

  • CyberTech Systems Earnings Raise Cash Flow Concerns Amid Market Stability
    May 20, 2026, 8:56 PM EDT. CyberTech Systems and Software Limited (NSE:CYBERTECH) posted earnings that met market expectations but revealed an accrual ratio of 0.53, indicating weaker free cash flow relative to profit. This financial metric, which measures non-cash earnings, signals potential challenges for upcoming profits as free cash flow of ₹76 million lagged behind reported profit of ₹304.3 million for the year ending March 2026. Despite a 28% annual growth in earnings per share (EPS) over three years, the decline in cash conversion may raise investor caution. The company's accrual ratio improved last year, suggesting the current shortfall could be temporary, but shareholders are advised to monitor cash flow trends closely against profitability for a clearer outlook.

Latest articles

SPAC ETF Up as SpaceX Heads for SPCX Ticker

SPAC ETF Up as SpaceX Heads for SPCX Ticker

21 May 2026
The SPAC and New Issue ETF, now trading as SPCK, closed up 0.64% at $22.09 on Wednesday after SpaceX filed for a $75 billion IPO under the fund’s old ticker. The fund reported $7.14 million in net assets and 41 holdings as of May 19. New listings included a $75 million IPO from Research Alliance III and filings from FutureCorp Space Acquisition 1 and JAB Acquisition I. The SEC proposed easing share issuance rules for public companies.
EnerSys Stock Flips After Earnings as Guidance Tops Trader Hopes

EnerSys Stock Flips After Earnings as Guidance Tops Trader Hopes

21 May 2026
EnerSys shares rose in after-hours trading after the company posted fourth-quarter adjusted earnings of $3.19 per share on $988 million in revenue, both above analyst estimates. The stock closed regular hours down 1.3% at $214.56, then quoted up 5.8% to $227. First-quarter profit guidance also topped forecasts. Management cited strong data center and defense demand, but noted continued weakness in motive-power and transportation.
Silexion Soars After Cancer Study, Liquidity and Nasdaq Issues Linger for SLXN

Silexion Soars After Cancer Study, Liquidity and Nasdaq Issues Linger for SLXN

21 May 2026
Silexion Therapeutics shares surged 97% to $0.5298 on Wednesday with over 325 million shares traded, then fell 9.5% after hours. The move followed news that Israel approved a Phase 2/3 trial of its lead pancreatic cancer drug, SIL204. Silexion reported a Q1 net loss of $2.7 million and $2.4 million in cash. The company plans a 1-for-10 reverse share split by early June.
Cogent Biosciences (COGT) stock jumps as FDA filing timeline sharpens — what investors watch next
Previous Story

Cogent Biosciences (COGT) stock jumps as FDA filing timeline sharpens — what investors watch next

Uber stock slips after NYC tipping report targets Uber Eats, as earnings date and new profit metrics loom
Next Story

Uber stock slips after NYC tipping report targets Uber Eats, as earnings date and new profit metrics loom

Go toTop